Cognoa Inc is a Palo Alto-based company that specializes in early childhood development and pediatric behavioral health. They are dedicated to providing digital diagnostics and therapeutics that enable earlier and more equitable access to care, ultimately improving the lives and outcomes of children and families.
With breakthrough innovations, Cognoa Inc offers a range of solutions, including Canvas Dx, the first and only FDA authorized diagnostic solution designed to diagnose or rule out autism in children aged 1.5 to 6 years within days, not months or years. Their objective, data-driven approach aims to alleviate prevalent biases in diagnoses and ensure that children receive timely care and interventions.
Generated from the website